{
    "2020-11-12": [
        [
            {
                "time": "2021-11-12",
                "original_text": "君实生物火速收问询函 PD-1产品安全性遭质疑 问询",
                "features": {
                    "keywords": [
                        "君实生物",
                        "PD-1",
                        "产品安全性",
                        "问询函"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "沪股通净卖出17.07亿元",
                "features": {
                    "keywords": [
                        "沪股通",
                        "净卖出"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "恒瑞医药治疗慢性心力衰竭药脯氨酸恒格列净片获临床试验批准",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "慢性心力衰竭",
                        "脯氨酸恒格列净片",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "中国生物制药抓住黄金机遇，龙头企业纷纷落户瑞士巴塞尔大区",
                "features": {
                    "keywords": [
                        "中国生物制药",
                        "黄金机遇",
                        "瑞士巴塞尔大区"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "盛视早参：周期萌动 科技承压",
                "features": {
                    "keywords": [
                        "周期萌动",
                        "科技承压"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "周期"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "陆股通连续净卖出股名单",
                "features": {
                    "keywords": [
                        "陆股通",
                        "净卖出"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "3款单抗拟纳入优先审评！百亿“K”药第七大新适应症来袭；默沙东、恒瑞、杨森",
                "features": {
                    "keywords": [
                        "单抗",
                        "优先审评",
                        "K药",
                        "恒瑞",
                        "默沙东",
                        "杨森"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "人民金融·创新药指数涨1.6% | 9个创新药临近上市，贝达药业重磅新药就要批了",
                "features": {
                    "keywords": [
                        "创新药指数",
                        "贝达药业",
                        "新药上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "信立泰之危：市盈率超过恒瑞医药 业绩却大跌62% 盈利能力下降",
                "features": {
                    "keywords": [
                        "信立泰",
                        "市盈率",
                        "恒瑞医药",
                        "业绩下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "君实生物H股跌近5%领跌医药股 市场关注医保谈判结果",
                "features": {
                    "keywords": [
                        "君实生物",
                        "H股",
                        "医保谈判"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}